U.S. Court of Appeals for the Federal Circuit, 2024

Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC

Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC
U.S. Court of Appeals for the Federal Circuit · Decided January 16, 2024

Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC

Opinion

Case: 23-1110 Document: 75 Page: 1 Filed: 01/16/2024

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ EAGLE PHARMACEUTICALS, INC., Plaintiff-Appellant v. SLAYBACK PHARMA LLC, APOTEX INC., APOTEX CORP., Defendants-Appellees ______________________ 2023-1110 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:21-cv-01256-CFC-JLH, Chief Judge Colm F. Connolly. ______________________ JUDGMENT ______________________ GREGORY G. GARRE, Latham & Watkins LLP, Washing- ton, DC, argued for plaintiff-appellant. Also represented by GABRIEL K. BELL, MICHAEL CLEMENTE; DANIEL BROWN, New York, NY; DAVID KOWALSKI, San Diego, CA.

CONSTANCE HUTTNER, Windels Marx Lane & Mitten- dorf, LLP, Madison, NJ, argued for defendant-appellee Slayback Pharma LLC. Also represented by JASON AARON LIEF.

Case: 23-1110 Document: 75 Page: 2 Filed: 01/16/2024

ERIC THOMAS WERLINGER, Katten Muchin Rosenman LLP, Washington, DC, argued for defendants-appellees Apotex Inc., Apotex Corp. Also represented by CHRISTOPHER FERENC, TIMOTHY H. GRAY; JOSEPH JANUSZ, JITENDRA MALIK, Charlotte, NC; DEEPRO MUKERJEE, LANCE SODERSTROM, New York, NY. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (LOURIE, PROST, and REYNA, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

January 16, 2024 Date

Case-law data current through December 31, 2025. Source: CourtListener bulk data.